-transparent.png){kind=logo}
We report a protocol for concomitant purification to homogeneity of both prostatic acid phosphatase [orthophosphoric-monoester phosphohydrolase (acid optimum), EC 3.1.3.2] and prostate-specific antigen, from human seminal fluid. The method requires only two chromatographic steps: passage through an Affigel-Blue column and gel filtration HPLC. This is a fast, efficient procedure for purification of these two important tumor markers, which are specific for prostatic cancer.
Related Publications
D Rusciano, and
A Berardi, and
C Ceccarini, and
B Terrana
May 1988,
Clinical chemistry,
D Rusciano, and
A Berardi, and
C Ceccarini, and
B Terrana
January 1979,
Methods in enzymology,
D Rusciano, and
A Berardi, and
C Ceccarini, and
B Terrana
August 2001,
Biochemical and biophysical research communications,
D Rusciano, and
A Berardi, and
C Ceccarini, and
B Terrana
April 2002,
Protein expression and purification,
D Rusciano, and
A Berardi, and
C Ceccarini, and
B Terrana
January 1981,
Comptes rendus des seances de la Societe de biologie et de ses filiales,
D Rusciano, and
A Berardi, and
C Ceccarini, and
B Terrana
January 1984,
Complement (Basel, Switzerland),
D Rusciano, and
A Berardi, and
C Ceccarini, and
B Terrana
February 1991,
Proceedings of the National Academy of Sciences of the United States of America,
D Rusciano, and
A Berardi, and
C Ceccarini, and
B Terrana
January 2015,
Bioscience, biotechnology, and biochemistry,
D Rusciano, and
A Berardi, and
C Ceccarini, and
B Terrana
March 1985,
Archives of biochemistry and biophysics,
D Rusciano, and
A Berardi, and
C Ceccarini, and
B Terrana
June 1998,
Biochemistry,
